Omega Plastics has expertise in the manufacturing of custom components and devices for drug delivery, diagnostic and orthopaedic medical applications
Omega Plastics manufactures custom components and devices for drug delivery and diagnostic applications. (Credit: fernando zhiminaicela from Pixabay)
TriMas, a provider of products for consumer, aerospace and industrial markets, has acquired US-based Omega Plastics for an undisclosed sum.
Omega Plastics, which will be added to TriMas Packaging, has expertise in the manufacturing of custom components and devices for drug delivery, diagnostic and orthopaedic medical applications. It also offers components for industrial applications.
Based in Clinton Township, Michigan, the company is an approved vendor to various major medical device companies.
Leveraging its advanced in-house tool making capabilities, injection moulding facility and ISO Class 8 clean room, the company offers a rapid product development cycle ranging from prototype development, testing and validation, to short and medium run production and assembly.
Omega, which presently runs as a private, family-owned company, is anticipated to generate revenue of around $18m in the fiscal year 2021.
TriMas president and CEO Thomas Amato said: “We look forward to expanding Omega’s production capacity to benefit its customers’ longer-term needs, while also leveraging Omega’s advanced tool making capabilities to add rapid prototyping to enhance TriMas Packaging’s speed-to-market advantage on innovation and new product designs.
“The addition of Omega further expands our Pharmaceutical & Nutraceutical product offerings into additional medical applications, which we believe is an attractive market for long-term growth.”
In July this year, TriMas Packaging’s Rieke announced the opening of a new automated plant in the US state of Ohio to expand its North American manufacturing operations.